NCT06361628|Unknown
Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine
RIVER-EU
Loading search results
RIVER-EU
Sponsor study identifier
interventional
1,000
4 countries
4
Study Start
May 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
June 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The goal of the study is to monitor and evaluate the implementation of interventions that aim to increase HPV \& MMR vaccines among underserved communities across four European countries: Greece, Netherlands, Poland, and Slovakia. The interventions will target identified health systems barriers in an earlier phase of the project. The interventions that will be implemented employ trusted community members as health promotors whom will provide educational sessions on HPV and MMR vaccination to the target groups. In addition, the cost-effectiveness of vaccine uptake strategies for the target groups is being evaluated. The main research question is: to what extent is the multicomponent tailored intervention effective to increase MMR/HPV intention and vaccine uptake in the target population in Greece, Netherlands, Poland and Slovakia?
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 20, 2024
Actual (reported)April 12, 2024
Actual (reported)May 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Intention to vaccinate MMR and/or HPV by questionnaire
Intention for vaccination against MMR and/or HPV among the underserved communities
Pre and immediately following the intervention and 6 month post intervention
Uptake of MMR and/or HPV vaccinations by questionnaire
Pre and 6 month post intervention evaluation is necessary
Knowledge concerning MMR and/or HPV vaccinations in the target group using a questionnaire
Pre and immediately following the intervention and 6 month post intervention evaluation
Communication skills of health care professionals using a questionnaire
Pre intervention and directly post intervention
Satisfaction of the stakeholders as measured by a questionnaire
Directly post intervention
Improved access to vaccinations by addressing identified health system barriers - number of barriers addressed
Through study completion, an average of 1 year
In this approach, medical professionals and health promoters-trusted members of the community-will educate refugee and migrant parents. The focus is on enhancing awareness of HPV/MMR and fostering a greater willingness to vaccinate their children/adolescents. Multicultural schools and migrant associations are the locations where the educational sessions will be provided.
Trusted community health members will be trained and will act as health promotors in the intervention. Together with health care professionals they will offer educational sessions on HPV vaccination at locations close to where people live (in the neighborhoods) and locations communities are familiar with, such as community centers, schools, health centers, religious places or offices of foundations/non-governmental organizations. Together with local stakeholders it will be verified that locations are also acceptable for the target communities. A navigation component is also included and participants will be contacted 1 week and 3 months after the educational sessions and reminded to get vaccinated and will be asked if they still have questions or need help to find their way to get vaccinated.
Educational sessions to create awareness on HPV and MMR (were addressed) vaccination that is culturally sensitive health information and provided in an easily understandable manner by trained health promoters (and healthcare professionals) to underserved communities. Support for navigation and access to vaccines.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Prolepsis
Athens, Athene, 151 25, Greece
University Medical Center Groningen
Groningen, 9713 GZ, Netherlands
University of Zielona Gora
Nikole Papaevgeniou, PhD
Prolepsis Institute for Preventive, Environmental and Occupational Medicine
Daniela Fiľakovská, PhD
UPJS
Maria Ganczak, MD PhD
University Zielona Gora
Michael Edelstein, MD PhD
Bar Ilan University
First Submitted
March 20, 2024
First Posted
April 12, 2024
Study Start
May 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
June 1, 2025
This intervention is based on the principle of face-to-face and online health education, where Ukrainian parents are educated by general practitioners to raise HPV/MMR awareness and increase willingness to child/adolescent vaccination.
Roma health mediators will be trained on HPV vaccination and thereafter will offer educational sessions to the underserved communities. Educational sessions take place at either municipalities, schools, community centers, local health care providers and public health authorities.
Contact the study team to confirm eligibility.
Zielona Góra, Lubusz Voivodeship, 65 417, Poland
PJ Šafárik University
Košice, Košice Region, 04180, Slovakia
Cornelis Boersma, PhD
University Medical Center Groningen
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 17, 2024
Record last verified: 2024-04
Sharing according to the European Union open research guidelines.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: